Could they not just licence globally to indications for which P2 completed and then use Acadia payments to finance the development to at least the same stage of yet to be released new indications?
- Forums
- ASX - By Stock
- NEU
- NEU is materially undervalued
NEU
neuren pharmaceuticals limited
Add to My Watchlist
2.28%
!
$12.54

NEU is materially undervalued, page-114
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.54 |
Change
0.280(2.28%) |
Mkt cap ! $1.559B |
Open | High | Low | Value | Volume |
$12.52 | $12.73 | $12.26 | $8.152M | 652.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 665 | $12.50 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.55 | 235 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 665 | 12.500 |
1 | 1537 | 12.470 |
1 | 1537 | 12.450 |
2 | 2037 | 12.420 |
1 | 42 | 12.400 |
Price($) | Vol. | No. |
---|---|---|
12.600 | 899 | 1 |
12.690 | 1537 | 1 |
12.720 | 2537 | 2 |
12.730 | 1010 | 1 |
12.750 | 1537 | 1 |
Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |